Currus Biologics
Currus Biologics is a biotech company in Melbourne, Australia, founded in 2021. It has 1 recorded funding round, most recently a Series A in June 2021.
Unlocking CAR T-cell therapy for solid tumours
- Headquarters
- Melbourne, Victoria
- Employees
- 1–10
- Founded
- 2021
- Website
- currusbio.com
- Last Round
- Series AJun 2021
- Rounds
- 1
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
Currus Biologics develops proprietary BEAT technology to unlock the use of CAR T-cell therapy for solid tumours.
Summary
It lists 1–10 employees. Its most recent funding was a Series A round in Jun 2021. Investors include Brandon Capital Partners and Uniseed.
Funding History
Jun 2021
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/currus-biologics"><img src="https://indexed.vc/api/badge/company/currus-biologics" alt="Currus Biologics on Indexed.vc" width="260" height="76" /></a>